Literature DB >> 1907544

In vitro activity of aztreonam, cefotaxime, ceftazidime and imipenem combined with ciprofloxacin against gram-negative bacilli and compared with amikacin combinations against Pseudomonas aeruginosa.

M Díez Enciso.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1907544     DOI： 10.1007/bf01964415

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  11 in total

Review 1.  Beta-lactam antibiotics.

Authors:  G N Rolinson
Journal:  J Antimicrob Chemother       Date:  1986-01       Impact factor: 5.790

2.  Synergism of the combinations of imipenem plus ciprofloxacin and imipenem plus amikacin against Pseudomonas aeruginosa and other bacterial pathogens.

Authors:  C I Bustamante; G L Drusano; R C Wharton; J C Wade
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

Review 3.  Synergy of fluoroquinolones with other antimicrobial agents.

Authors:  H C Neu
Journal:  Rev Infect Dis       Date:  1989 Jul-Aug

4.  Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods.

Authors:  J A Moody; D N Gerding; L R Peterson
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

5.  Synergy of imipenem--a novel carbapenem, and rifampin and ciprofloxacin against Pseudomonas aeruginosa, Serratia marcescens and Enterobacter species.

Authors:  N X Chin; H C Neu
Journal:  Chemotherapy       Date:  1987       Impact factor: 2.544

Review 6.  Synergistic combinations of antibiotics in gram-negative bacillary infections.

Authors:  J Klastersky; S H Zinner
Journal:  Rev Infect Dis       Date:  1982 Mar-Apr

7.  Antimicrobial synergism in the therapy of gram-negative rod bacteremia.

Authors:  E T Anderson; L S Young; W L Hewitt
Journal:  Chemotherapy       Date:  1978       Impact factor: 2.544

8.  In vitro evaluation of N-formimidoyl thienamycin (MK0787) combined with amikacin against gram-negative bacilli and Staphylococcus aureus.

Authors:  M Díez Enciso; M Mateos Lindemann; A Gutiérrez Altés
Journal:  Antimicrob Agents Chemother       Date:  1982-12       Impact factor: 5.191

9.  In-vitro study of the activity of ciprofloxacin alone and in combination against strains of Pseudomonas aeruginosa with multiple antibiotic resistance.

Authors:  G S Davies; J Cohen
Journal:  J Antimicrob Chemother       Date:  1985-12       Impact factor: 5.790

10.  Comprehensive evaluation of ciprofloxacin-aminoglycoside combinations against Enterobacteriaceae and Pseudomonas aeruginosa strains.

Authors:  I Haller
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191
View more
  2 in total

1.  Synergistic activities of gatifloxacin in combination with other antimicrobial agents against Pseudomonas aeruginosa and related species.

Authors:  E Gradelski; L Valera; D Bonner; J Fung-Tomc
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

Review 2.  Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.

Authors:  R Davis; A Markham; J A Balfour
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.